Hebei, China

Qian Guo

This inventor holds 1 USPTO granted patent. Top assignee: Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qian Guo. Retrieved from https://idiyas.com/inventor/qian-guo-3buljm2p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qian Guo: Innovator in Pharmaceutical Technology

Introduction

Qian Guo is a notable inventor based in Hebei, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of compounds that address critical health conditions.

Latest Patents

Qian Guo holds a patent for a 1,7-naphthyridine derivative and its preparation method and use. This compound, represented by formula (I), along with its tautomer, optical isomer, nitrogen oxide, solvate, pharmaceutically acceptable salt, or prodrug, is useful for treating or relieving diseases or conditions related to HIF and EPO in patients. The patent also outlines the preparation method for the compound and the use of a drug composition containing it.

Career Highlights

Qian Guo is associated with Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., where he has been instrumental in advancing pharmaceutical research and development. His work has led to innovative solutions that enhance patient care and treatment options.

Collaborations

Qian Guo collaborates with talented individuals such as Yan Zhang and Miaomiao Wei, who contribute to the success of their projects and initiatives.

Conclusion

Qian Guo's innovative work in pharmaceutical technology exemplifies the impact of research and development in improving healthcare solutions. His contributions continue to pave the way for advancements in the treatment of critical health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…